currence of two cases of thrombotic thrombocytopenic
Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection
β Scribed by Erik De Clercq
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 444 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0198-6325
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The prevalence of human immunodeficiency virus (HIV) infection can be estimated by two distinct methods. One method, back-calculation, is a complex statistical procedure that estimates the HIV epidemic curve. The second method is based on data from population-based surveys, which provide estimates o
## Background: In addition to kaposi's sarcoma and non-hodgkin's lymphomas, it has been postulated that human immunodeficiency virus (hiv) infection may increase the risk of other cancers. the aim of the current study was to compare incidence rates of cancer among individuals who seroconverted for
Hepatits C (HCV) infection is frequent among hemophilic patients treated with non-inactivated factor-concentrates. Both HCV genotype and viral load have been suggested to be important prognostic markers of disease progression and treatment outcome. In addition, co-infection with the human immunodefi
Over the past decade the cognitive approach to depression has received considerable attention. The impetus for this stems from empirical and theoretical reports of its efficacy in its application to the treatment of depressed individuals . This paper examines the theory and practice of cognitive beh
## BACKGROUND. There is very little experience reported in the literature on the treatment of patients with relapsed or resistant human immunodeficiency virus-related non-Hodgkin's lymphoma (HIV-NIIL). We performed a prospective study to ovaluate the feasibility and activity of a second-line chemo